DK3366285T3 - Alfa-derivater af cis-monoumættede fedtsyrer til anvendelse som medicin - Google Patents

Alfa-derivater af cis-monoumættede fedtsyrer til anvendelse som medicin Download PDF

Info

Publication number
DK3366285T3
DK3366285T3 DK18164265.3T DK18164265T DK3366285T3 DK 3366285 T3 DK3366285 T3 DK 3366285T3 DK 18164265 T DK18164265 T DK 18164265T DK 3366285 T3 DK3366285 T3 DK 3366285T3
Authority
DK
Denmark
Prior art keywords
alfa
cis
mono
medicine
derivatives
Prior art date
Application number
DK18164265.3T
Other languages
Danish (da)
English (en)
Inventor
Xaubet Xavier Busquets
Ruiz Pablo Vicente Escribá
Original Assignee
Univ Illes Balears
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42242375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3366285(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Illes Balears filed Critical Univ Illes Balears
Application granted granted Critical
Publication of DK3366285T3 publication Critical patent/DK3366285T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
DK18164265.3T 2008-12-09 2009-12-04 Alfa-derivater af cis-monoumættede fedtsyrer til anvendelse som medicin DK3366285T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200803480A ES2342997B1 (es) 2008-12-09 2008-12-09 Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento.
EP14195394.3A EP2842555B1 (en) 2008-12-09 2009-12-04 Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines in the treatment of diabetes

Publications (1)

Publication Number Publication Date
DK3366285T3 true DK3366285T3 (da) 2021-10-04

Family

ID=42242375

Family Applications (3)

Application Number Title Priority Date Filing Date
DK18164265.3T DK3366285T3 (da) 2008-12-09 2009-12-04 Alfa-derivater af cis-monoumættede fedtsyrer til anvendelse som medicin
DK14195436.2T DK2842556T3 (en) 2008-12-09 2009-12-04 Alpha derivatives of cis monounsaturated fatty acids for use as medicine
DK09831504.7T DK2374453T3 (en) 2008-12-09 2009-12-04 ALFA-DERIVATIVES OF CIS-monounsaturated fatty acids for use as medicaments

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK14195436.2T DK2842556T3 (en) 2008-12-09 2009-12-04 Alpha derivatives of cis monounsaturated fatty acids for use as medicine
DK09831504.7T DK2374453T3 (en) 2008-12-09 2009-12-04 ALFA-DERIVATIVES OF CIS-monounsaturated fatty acids for use as medicaments

Country Status (18)

Country Link
US (3) US9000042B2 (enExample)
EP (4) EP2842556B1 (enExample)
JP (2) JP5711140B2 (enExample)
KR (1) KR101683643B1 (enExample)
CN (1) CN102355897B (enExample)
AU (6) AU2009326993B2 (enExample)
BR (1) BRPI0922870A8 (enExample)
CA (1) CA2745052C (enExample)
DK (3) DK3366285T3 (enExample)
ES (5) ES2342997B1 (enExample)
HU (2) HUE037396T2 (enExample)
IL (1) IL213354A (enExample)
MX (1) MX2011005978A (enExample)
PL (3) PL2842556T3 (enExample)
PT (4) PT2842556T (enExample)
RU (1) RU2531353C2 (enExample)
SI (1) SI3366285T1 (enExample)
WO (1) WO2010066931A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2342997B1 (es) 2008-12-09 2011-06-06 Universitat De Les Illes Balears Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento.
WO2011089265A1 (en) * 2010-01-25 2011-07-28 Bridge Bioresearch Plc Use of fatty acid compounds for lowering blood glucose levels
ES2401629B1 (es) 2011-10-07 2014-03-04 Universitat De Les Illes Balears Enantiómeros de 2-hidroxiderivados de ácidos grasos y su uso como medicamentos.
WO2013132092A1 (en) 2012-03-09 2013-09-12 Pensieve International Plc Use of monounsaturated fatty acid compounds for controlling the body weight of a dog or a cat
WO2016062746A1 (en) 2014-10-21 2016-04-28 Universitat De Les Illes Balears Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treatment of diseases
US11771672B2 (en) * 2017-11-16 2023-10-03 The Research Foundation For The State University Of New York Use of 2-hydroxyoleic acid for the treatment of systemic lupus erythematosus and other immune pathologies
KR20220132552A (ko) * 2020-01-29 2022-09-30 유니버시다드 데 레스 일레스 발레아르스 알파-히드록실화 지방산의 대사산물, 이의 의학적 용도 및 바이오마커로서의 용도
ES2911474B2 (es) * 2020-11-17 2023-02-06 Univ Illes Balears Profarmacos de acidos grasos monoinsaturados y sus metabolitos: usos medicos y como biomarcadores
US12440467B2 (en) * 2021-12-09 2025-10-14 The Florida International University Board Of Trustees Treatment and prevention of infections using vegetable oil-derived polyols

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4928172B1 (enExample) * 1969-10-27 1974-07-24
CH558321A (de) * 1971-08-03 1975-01-31 Ciba Geigy Ag Verfahren zur herstellung von carbonsaeuren bezw. carbonsaeuresalzen.
US3931306A (en) 1973-10-23 1976-01-06 International Flavors & Fragrances Inc. Process for producing isomer mixtures containing high proportions of cis-2-methyl-3-pentenoic acid
DE2448339A1 (de) * 1974-10-10 1976-04-22 Basf Ag Verfahren zur herstellung von olefinisch ungesaettigten carbonsaeureestern
DE2559201B2 (de) * 1975-12-30 1978-06-15 Hoechst Ag, 6000 Frankfurt Organozinnverbindungen und ihre Verwendung als Stabilisatoren
US4241097A (en) * 1979-09-13 1980-12-23 International Flavors & Fragrances Inc. Use of benzodionones in augmenting or enhancing the aroma and taste of a foodstuff
US4391757A (en) * 1981-11-27 1983-07-05 Carstab Corporation Organic antimony containing stabilizer compositions for halogenated polymers
JPS5899432A (ja) * 1981-12-09 1983-06-13 Maruzen Sekiyu Kagaku Kk 不飽和脂肪酸またはその塩およびそれからなる抗菌剤
US4551279A (en) * 1984-01-09 1985-11-05 G. D. Searle & Co. Protease inhibitors
FR2609032B1 (fr) * 1986-12-30 1990-01-05 Centre Nat Rech Scient Epoxydes fonctionnels enantiomeriquement purs, leur procede de preparation et leur application comme synthons chiraux
US4808403A (en) * 1987-03-17 1989-02-28 International Flavors & Fragrances Inc. Use of N,N-diethyl-m-toluamide and/or the ethyl ester of 2-methyl-3-pentenoic acid as insect attractants
US5504107A (en) 1990-01-12 1996-04-02 The Ohio State University Research Foundation Optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids and pharmaceutical use thereof
GB9003201D0 (en) * 1990-02-13 1990-04-11 Unilever Plc Cosmetic composition
US5208260A (en) * 1990-03-29 1993-05-04 G. D. Searle & Co. Vinyl Glycine derivatives for memory and learning enhancement or treatment of a cognitive disorder
US5198250A (en) 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
ES2039336T3 (es) * 1991-04-10 1999-08-01 Yu Ruey J Uso de composiciones cosmeticas que contienen acidos 2-hidroxicarboxilicos y compuestos afines para aliviar los indicios de cambios de las uñas.
US6300373B1 (en) 1993-09-10 2001-10-09 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
JP3489703B2 (ja) * 1995-10-23 2004-01-26 株式会社ノエビア 微細エマルション組成物
US5856537A (en) * 1996-06-26 1999-01-05 The Scripps Research Institute Inhibitors of oleamide hydrolase
JPH10182338A (ja) * 1996-12-20 1998-07-07 Noevir Co Ltd 水中油型乳化組成物
AU740588B2 (en) * 1997-11-24 2001-11-08 Scripps Research Institute, The Inhibitors of gap junction communication
GB9926833D0 (en) * 1999-11-15 2000-01-12 Univ Sunderland Compositions
GB2385589A (en) * 2000-08-07 2003-08-27 Sofitech Nv Surfactant
ES2186576B1 (es) * 2001-10-11 2004-09-16 Universitat De Les Illes Balears Acido 2-hidroxioleico para utilizar como medicamento.
US6702756B2 (en) * 2001-12-11 2004-03-09 University Technologies International Inc. Method and apparatus for diagnosing neurological impairment
HUP0402592A2 (hu) 2002-01-22 2005-04-28 Syngenta Participations Ag Herbicidekként hasznosítható fenil-szubsztituált heterociklusos vegyületek
US7462349B2 (en) * 2002-10-24 2008-12-09 Nurit Kalderon Beta interferon for the treatment of chronic spinal cord injury
US20040214215A1 (en) 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
EP2517718B1 (en) * 2003-05-15 2016-03-02 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
ES2229935B1 (es) * 2003-10-10 2006-10-01 Universitat De Les Illes Balears Utilizacion del acido hidroxioleico y compuestos analagos del mismo como aditivos alimentarios funcionales.
KR100756890B1 (ko) * 2005-08-19 2007-09-07 경희대학교 산학협력단 신경세포 보호활성을 갖는 올레산을 함유하는 조성물
JP2009051732A (ja) * 2005-12-13 2009-03-12 Meiji Seika Kaisha Ltd Ｐｐａｒリガンド活性を有する組成物
WO2009127009A1 (en) 2008-04-18 2009-10-22 Commonwealth Scientific And Industrial Research Organisation Condensation polymers
AU2009238222A1 (en) 2008-04-18 2009-10-22 Commonwealth Scientific And Industrial Research Organisation Polyurethanes
ES2342997B1 (es) * 2008-12-09 2011-06-06 Universitat De Les Illes Balears Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento.

Also Published As

Publication number Publication date
BRPI0922870A8 (pt) 2017-12-26
AU2019222955B2 (en) 2020-11-05
EP2374453A1 (en) 2011-10-12
AU2009326993B2 (en) 2016-06-16
WO2010066931A4 (es) 2010-08-05
JP2012511510A (ja) 2012-05-24
AU2016228167A1 (en) 2016-09-29
CN102355897B (zh) 2014-06-04
IL213354A (en) 2017-06-29
ES2535498T8 (es) 2016-08-19
PL2374453T3 (pl) 2015-07-31
AU2018229474A1 (en) 2018-10-04
ES2342997B1 (es) 2011-06-06
PT2842555T (pt) 2018-07-06
AU2018229472B2 (en) 2019-07-18
ES2899274T3 (es) 2022-03-10
EP3366285A1 (en) 2018-08-29
PL2842556T3 (pl) 2018-07-31
AU2016228171A1 (en) 2016-09-29
ES2673406T3 (es) 2018-06-21
ES2342997A1 (es) 2010-07-20
HUE056170T2 (hu) 2022-01-28
CA2745052A1 (en) 2010-06-17
US20110294883A1 (en) 2011-12-01
RU2531353C2 (ru) 2014-10-20
US20180193297A1 (en) 2018-07-12
KR101683643B1 (ko) 2016-12-07
KR20110126100A (ko) 2011-11-22
ES2535498T3 (es) 2015-05-12
JP2015061856A (ja) 2015-04-02
WO2010066931A1 (es) 2010-06-17
RU2011128335A (ru) 2013-01-20
EP2842555B1 (en) 2018-04-18
HUE037396T2 (hu) 2018-08-28
EP2374453A4 (en) 2012-05-30
CN102355897A (zh) 2012-02-15
US9000042B2 (en) 2015-04-07
EP2842555A3 (en) 2015-04-15
AU2009326993A1 (en) 2011-07-07
EP2842556B1 (en) 2018-01-31
AU2018229472A1 (en) 2018-10-04
DK2374453T3 (en) 2015-03-30
AU2019222955A1 (en) 2019-09-19
PT2374453E (pt) 2015-04-28
PT2842556T (pt) 2018-03-19
EP2842556A3 (en) 2015-08-05
ES2661412T3 (es) 2018-03-28
IL213354A0 (en) 2011-07-31
US10588883B2 (en) 2020-03-17
AU2018229474B2 (en) 2019-08-22
PL3366285T3 (pl) 2022-01-10
SI3366285T1 (sl) 2021-11-30
EP3366285B1 (en) 2021-06-30
EP2374453B1 (en) 2015-02-18
PT3366285T (pt) 2021-10-07
CA2745052C (en) 2017-11-07
US20150297548A1 (en) 2015-10-22
MX2011005978A (es) 2011-10-11
EP2842556A2 (en) 2015-03-04
DK2842556T3 (en) 2018-03-26
BRPI0922870A2 (pt) 2016-01-12
JP5711140B2 (ja) 2015-04-30
EP2842555A2 (en) 2015-03-04
US9730906B2 (en) 2017-08-15

Similar Documents

Publication Publication Date Title
DK3159329T3 (da) Anvendelse af 2-hidroxyderivater af polyumættede fedtsyrer som medikamenter
DK3366285T3 (da) Alfa-derivater af cis-monoumættede fedtsyrer til anvendelse som medicin
DK2231606T3 (da) Fremgangsmåder til fremstilling af cycloalkylcarboxamidopyridinbenzoesyrer
DK2310437T3 (da) Fremgangsmåde til kontinuerlig fremstilling af polyestere
DK2119791T3 (da) Fremgangsmåde til fremstilling af flerumættede fedtsyrer
EP2421525A4 (en) NEW DICLOFEN AC FORMULATION
BRPI0814026A2 (pt) Modificação química de ácidos gordos maleatados
DK2596786T3 (da) Anvendelse af eicosapentaensyreethylester til behandling af hypertriglyceridæmi
EP2498843A4 (en) CLINICAL SYRINGE
EP2421512A4 (en) NEW NAPROXE FORMULATION
DK2424520T3 (da) Anvendelse af flerumættede fedtsyrer til behandling af hudinflammation
DK2421537T3 (da) Pyrazolylaminopyridiner som inhibitorer af FAK
DK2381965T3 (da) Modulation af præ-mrna under anvendelse af splejsningsmodulerende oligonukleotider som terapeutiske midler til behandling af sygdom
DK2496263T3 (da) Lipidlagsdannende sammensætning til administration på en overflade af en levende organisme
DK1996536T3 (da) Fremgangsmåde til decarboxylering af fedtsyrer
BRPI0915032A2 (pt) hidrogenação de alcanos multi-bromados
DK2164520T3 (da) Cyclodextriner til indgivelse af fedtsyrer i tabletter
DK2247200T3 (da) Anvendelse af alternan som bestanddel til visse fødevarer
PT2271348T (pt) Formulação de comprimido oral de composto de tetraciclina
BR112014014725A8 (pt) método de produção de uma composição líquida estruturada que compreende água, um composto graxo e um tensoativo catiônico, líquido estruturado e uso de líquido estruturado
DK2462108T3 (da) Fremgangsmåde til fremstilling af pyrazolcarboxylsyreamider
BRPI0818702A2 (pt) Formulação farmacêutica de ácido clavulânico
CU23884B1 (es) Derivados de dibenzotiazepina
DK2245001T3 (da) Fremgangsmåde til fremstilling af 2-fluoracyl-3-amino-acrylsyrederivater
EP2655077A4 (en) Optically clear fluid composition